About Senescence
Senescence is a company based in Singapore (Singapore) founded in 2015 by Shawn Watson. It operates as a D2C and B2C. Senescence offers products and services including SLS Nutraceuticals, SLS Performance, and SLS Pharmaceuticals. Senescence operates in a competitive market with competitors including Quincy Bioscience, First Person Group, BrainGear, Procera Health and Smile Migraine, among others.
- Headquarter Singapore, Singapore
- Founders Shawn Watson
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Senescence Life Sciences Pte. Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Senescence
Senescence offers a comprehensive portfolio of products and services, including SLS Nutraceuticals, SLS Performance, and SLS Pharmaceuticals.
Brain health supplements for consumer cognitive optimization and performance.
Products targeting decision fatigue in athletes and e-sports professionals.
Clinically-focused treatments for neurodegenerative diseases and cognitive decline.
Funding Insights of Senescence
Detailed funding history for Senescence
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Senescence
Investment portfolio details for Senescence
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Senescence
Detailed financials for Senescence
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Senescence Comparisons
Peer comparison for Senescence
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Senescence
Senescence operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Quincy Bioscience, First Person Group, BrainGear, Procera Health and Smile Migraine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel technologies for cognitive support in aging are developed.
|
|
| Locked | Locked | Locked |
Functional mushroom ingredients for mental health are supplied.
|
|
| Locked | Locked | Locked |
Nutrient supplements for brain health are developed.
|
|
| Locked | Locked | Locked |
Nutritional products for brain health and cognitive function are provided.
|
|
| Locked | Locked | Locked |
Delivers dietary supplements to help reduce migraine headaches.
|
|
| Locked | Locked | Locked |
Natural supplements for mental wellness issues are provided.
|
Detailed competitors of Senescence
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Senescence
Complete news archive for Senescence
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Senescence
Senescence was founded in 2015.
Senescence is headquartered in Singapore, Singapore.
Shawn Watson is the current CEO of Senescence. They have also founded this company.
Senescence Life Sciences is a biotechnology company that focuses on optimizing brain health using advances in neuroscience. They create nutritional products like SLS Nutraceuticals for consumers and SLS Performance for athletes, as well as pharmaceuticals for treating cognitive decline. Based in Singapore, the company targets age-related issues through enzymatic processes to improve learning and memory. Their solutions address neurodegenerative diseases without specifying particular clients.
Senescence's top competitors include Quincy Bioscience, First Person Group and Procera Health.
Senescence offers SLS Nutraceuticals, SLS Performance, and SLS Pharmaceuticals.